From Liston Street Pulse:
According to Bloomberg, citing sources familiar with the matter as saying, drug maker, Dendreon Corp. (DNDN), is looking to sell its business after Provenge, its leading treatment for prostate cancer clocked weaker-than-expected sales. Bloomberg said that the Seattle based drug maker has hired JP Morgan Chase & Co to find […]
The post Dendreon Putting itself up for Sale: Bloomberg appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015